References
- Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood 1958;13:609–630.
- Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984;310:15–18.
- Spiers AS, Parekh SJ. Complete remission in hairy cell leukaemia achieved with pentostatin. Lancet 1984;1:1080–1081.
- Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet 1992;340:952–956.
- Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117–1121.
- Liliemark J, Juliusson G. On the pharmacokinetics of 2-chloro-2′-deoxyadenosine in humans. Cancer Res 1991;51:5570–5572.
- Liliemark J, Juliusson G. Cellular pharmacokinetics of 2-chloro-2′-deoxyadenosine nucleotides: comparison of intermittent and continuous intravenous infusion and subcutaneous and oral administration in leukemia patients. Clin Cancer Res 1995;1:385–390.
- Liliemark J, Albertioni F, Hassan M, Juliusson G. On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine in humans: alternative routes of administration. J Clin Oncol 1992;10:1514–1518.
- Juliusson G, Heldal D, Hippe E, Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol 1995;13:989–995.
- Juliusson G, Christiansen I, Hansen MM, Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia. J Clin Oncol 1996;14:2160–2166.
- Giovannoni G, Comi G, Cook S, A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 2010;362:416–426.
- Juliusson G, Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-deoxyadenosine (CdA): relation to opportunistic infections. Blood 1992;79:888–894.
- Juliusson G, Lenkei R, Tjonnfjord G, Heldal D, Liliemark J. Low-dose cladribine for symptomatic hairy cell leukaemia. Br J Haematol 1995;89:637–639.